China NMPA Drug Inspection - Huaihua Rheumatology Research Institute Affiliated Tianxing Hospital - Rheumatoid Capsules
China NMPA drug inspection for Huaihua Rheumatology Research Institute Affiliated Tianxing Hospital published January 22, 2018. Drug: Rheumatoid Capsules. The Hunan Provincial Food and Drug Administration published its 2018 First Issue Drug Quality Bulletin, detailing result
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Huaihua Rheumatology Research Institute Affiliated Tianxing Hospital published January 22, 2018. Drug: Rheumatoid Capsules. The Hunan Provincial Food and Drug Administration published its 2018 First Issue Drug Quality Bulletin, detailing result
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox